Press Releases
Press Release
Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”
August 09, 2021
Press Release
Cardiol Therapeutics’ Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman
July 07, 2021
Press Release
Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting
June 30, 2021
Press Release
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDT
June 28, 2021
Press Release
Cardiol Therapeutics Closes $22 Million Bought Deal Offering
May 12, 2021
Press Release
Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering
May 06, 2021
Press Release
Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering
May 05, 2021
Press Release
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19
April 28, 2021
Press Release
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx™
April 12, 2021